FR2959668B1 - Association pharmaceutique contenant l'acide lipoique, l'acide hydroxycitrique et une somatostatine a titre de principes actifs - Google Patents

Association pharmaceutique contenant l'acide lipoique, l'acide hydroxycitrique et une somatostatine a titre de principes actifs

Info

Publication number
FR2959668B1
FR2959668B1 FR1053504A FR1053504A FR2959668B1 FR 2959668 B1 FR2959668 B1 FR 2959668B1 FR 1053504 A FR1053504 A FR 1053504A FR 1053504 A FR1053504 A FR 1053504A FR 2959668 B1 FR2959668 B1 FR 2959668B1
Authority
FR
France
Prior art keywords
acid
somatostatin
active ingredients
pharmaceutical association
hydroxycitric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1053504A
Other languages
English (en)
Other versions
FR2959668A1 (fr
Inventor
Laurent Schwartz
Adeline Guais-Vergne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOREBUS
Original Assignee
BIOREBUS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOREBUS filed Critical BIOREBUS
Priority to FR1053504A priority Critical patent/FR2959668B1/fr
Priority to PCT/FR2011/051025 priority patent/WO2011138565A1/fr
Publication of FR2959668A1 publication Critical patent/FR2959668A1/fr
Application granted granted Critical
Publication of FR2959668B1 publication Critical patent/FR2959668B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR1053504A 2010-05-05 2010-05-05 Association pharmaceutique contenant l'acide lipoique, l'acide hydroxycitrique et une somatostatine a titre de principes actifs Expired - Fee Related FR2959668B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1053504A FR2959668B1 (fr) 2010-05-05 2010-05-05 Association pharmaceutique contenant l'acide lipoique, l'acide hydroxycitrique et une somatostatine a titre de principes actifs
PCT/FR2011/051025 WO2011138565A1 (fr) 2010-05-05 2011-05-05 Association pharmaceutique contenant l'acide lipoïque, l'acide hydroxycitrique et une somatostatine a titre de principes actifs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1053504A FR2959668B1 (fr) 2010-05-05 2010-05-05 Association pharmaceutique contenant l'acide lipoique, l'acide hydroxycitrique et une somatostatine a titre de principes actifs

Publications (2)

Publication Number Publication Date
FR2959668A1 FR2959668A1 (fr) 2011-11-11
FR2959668B1 true FR2959668B1 (fr) 2012-07-13

Family

ID=42735757

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1053504A Expired - Fee Related FR2959668B1 (fr) 2010-05-05 2010-05-05 Association pharmaceutique contenant l'acide lipoique, l'acide hydroxycitrique et une somatostatine a titre de principes actifs

Country Status (1)

Country Link
FR (1) FR2959668B1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1124820B1 (fr) * 1998-10-26 2004-09-22 The Research Foundation Of State University Of New York Derives d'acide lipoique et leurs utilisation pour le traitement des maladies
US6284786B1 (en) * 1999-02-16 2001-09-04 The Center For The Improvement Of Human Functioning, Int'l., Inc. Treatment of cancer using lipoic acid in combination with ascorbic acid
IT1312060B1 (it) * 1999-04-09 2002-04-04 Antibioticos Spa Uso dell'acido alfa lipoico nel trattamento antimetastatico.
JP5172146B2 (ja) * 2003-05-09 2013-03-27 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア 癌を標的化するための組成物及び方法
JPWO2009008461A1 (ja) * 2007-07-10 2010-09-09 株式会社グリフィンバイオテック 性ホルモン感受性細胞増殖を原因とする疾患に対する医薬組成物

Also Published As

Publication number Publication date
FR2959668A1 (fr) 2011-11-11

Similar Documents

Publication Publication Date Title
HRP20171175T1 (hr) Novi triciklički spojevi
DOP2012000011A (es) Formulacion farmaceutica
RS53559B1 (en) INSULIN FORMULATIONS WITH LONG TERM ACTION
HRP20240168T1 (hr) Kombinacije dolutegravira i lamivudina za liječenje hiv infekcije
MX2015003653A (es) Derivados de amida del acido benzoimidazol-carboxilico como moduladores del receptor apj.
EA201201050A1 (ru) Пиразолы в качестве антагонистов crth2
CR20130259A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso
BR112014010576A2 (pt) inibidores de neprilisina
MY183588A (en) New salvianolic acid compound l, preparation method and use thereof
EA201291089A1 (ru) Способ получения фармацевтических препаратов, предназначенных для перорального введения, содержащих один или более активных ингредиентов, и содержащих их композиций
EA201492091A1 (ru) Фармацевтические композиции для местного применения, содержащие тербинафид и мочевину
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
TN2013000386A1 (en) Suspension type topical formulations comprising cyclic depsipeptide
FR2981572B1 (fr) Compositions pharmaceutiques d'acide ursodesoxycholique
EA201490573A1 (ru) Соединение бензотиазолона
EA201390950A1 (ru) Гомогенные фармацевтические пероральные лекарственные формы, содержащие лерканидипин и эналаприл или их фармацетически приемлемые соли совместно с органической кислотой
FR2937867B1 (fr) Association pharmaceutique contenant l acide lipoique et l acide hydroxycitrique a titre de principes actifs.
ZA201404068B (en) The use of silver(i) complexes as active pharmaceutical ingredients (api's) iincluding anticancer agents
ATE511837T1 (de) Wässrige arzneimittelformulierung von 4-ä((4- carboxybutyl)-ä2-ä(4-phenethyl-benzyl)oxyü- phenethylüamino)methylübenzoesäure
FR2999934B1 (fr) Composition pharmaceutique sous la forme d'une suspension orale comprenant une fraction flavonoique et de la gomme xanthane
FR2959668B1 (fr) Association pharmaceutique contenant l'acide lipoique, l'acide hydroxycitrique et une somatostatine a titre de principes actifs
CN102369976A (zh) 禽肉保鲜剂
UY32894A (es) Derivados de 5-fenil-pirazolopiridina, su preparación y su aplicación en terapéutica
WO2014045046A3 (fr) Préparations de substances médicamenteuses, compositions pharmaceutiques et formes pharmaceutiques comprenant du s-(+)-flurbiprofène
AR083322A1 (es) Compuesto (3-{[{4-[4-amino-2-(etoximetil)-1h-imidazol[4,5-c]quinolin-1-il]butil}(n,n-dietilglicil)amino]metil}fenil)acetato de metilo

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140131